中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2010年
6期
493-496
,共4页
王云龙%郭继鸿%李学斌%任学军%韩智红%陈方
王雲龍%郭繼鴻%李學斌%任學軍%韓智紅%陳方
왕운룡%곽계홍%리학빈%임학군%한지홍%진방
心动过速,异位房性%心耳%导管消融术%电生理学
心動過速,異位房性%心耳%導管消融術%電生理學
심동과속,이위방성%심이%도관소융술%전생이학
Tachycardia,ectopic atrial%Atrial appendage%Catheter ablation%Electrophysiology
目的 报道一组起源于左心耳局灶性房性心动过速(房速)的电生理特征和射频消融治疗.方法 9例患者中男性5例,平均年龄(21±9)岁,经心内电生理检查和射频消融证实为起源于左心耳的房速,对其电生理特点及射频消融进行分析.结果 左心耳房速表现为无休止性或静脉滴注异丙肾上腺素诱发,程序刺激不能诱发或终止房速.左心耳房速有独特的体表心电图特征,所有患者P波Ⅰ、aVL导为负向,Ⅱ、Ⅲ、aVF导联P波高而直立.V_1导P波为直立或正负双向(以直立为主),V_2~V_6导P波为等电位线(5例)或<0.1 mV低幅直立(4例).常规心内标测,最早心房激动为CS远端.成功靶点处局部心房激动领先P波起始(36.7±7.9)ms.5例患者最终使用盐水灌注导管消融成功,随访(12 ±5)个月无房速复发.结论 左心耳房速有独特的心电图特征和房内激动顺序,对这类房速盐水灌注导管可能是更好的选择,左心耳内局灶消融长期随访安全有效.
目的 報道一組起源于左心耳跼竈性房性心動過速(房速)的電生理特徵和射頻消融治療.方法 9例患者中男性5例,平均年齡(21±9)歲,經心內電生理檢查和射頻消融證實為起源于左心耳的房速,對其電生理特點及射頻消融進行分析.結果 左心耳房速錶現為無休止性或靜脈滴註異丙腎上腺素誘髮,程序刺激不能誘髮或終止房速.左心耳房速有獨特的體錶心電圖特徵,所有患者P波Ⅰ、aVL導為負嚮,Ⅱ、Ⅲ、aVF導聯P波高而直立.V_1導P波為直立或正負雙嚮(以直立為主),V_2~V_6導P波為等電位線(5例)或<0.1 mV低幅直立(4例).常規心內標測,最早心房激動為CS遠耑.成功靶點處跼部心房激動領先P波起始(36.7±7.9)ms.5例患者最終使用鹽水灌註導管消融成功,隨訪(12 ±5)箇月無房速複髮.結論 左心耳房速有獨特的心電圖特徵和房內激動順序,對這類房速鹽水灌註導管可能是更好的選擇,左心耳內跼竈消融長期隨訪安全有效.
목적 보도일조기원우좌심이국조성방성심동과속(방속)적전생리특정화사빈소융치료.방법 9례환자중남성5례,평균년령(21±9)세,경심내전생리검사화사빈소융증실위기원우좌심이적방속,대기전생리특점급사빈소융진행분석.결과 좌심이방속표현위무휴지성혹정맥적주이병신상선소유발,정서자격불능유발혹종지방속.좌심이방속유독특적체표심전도특정,소유환자P파Ⅰ、aVL도위부향,Ⅱ、Ⅲ、aVF도련P파고이직립.V_1도P파위직립혹정부쌍향(이직립위주),V_2~V_6도P파위등전위선(5례)혹<0.1 mV저폭직립(4례).상규심내표측,최조심방격동위CS원단.성공파점처국부심방격동령선P파기시(36.7±7.9)ms.5례환자최종사용염수관주도관소융성공,수방(12 ±5)개월무방속복발.결론 좌심이방속유독특적심전도특정화방내격동순서,대저류방속염수관주도관가능시경호적선택,좌심이내국조소융장기수방안전유효.
Objective To analyze the electrophysiological characteristics and efficacy of radiofrequeney catheter ablation ( RFA ) of focal atrial tachycardia (AT) originating from the left atrial appendage (LAA). Methods Electrophysiologic study and RFA were performed in 9 patients (4 female)with focal AT originating from the LAA. Atrial appendage angiography was performed to identify the origin of AT. P waves were classified as negative, positive, isoelectric, or biphasic. Results The mean age was (21 ±9)years. AT occurred spontaneously or was induced by isoproterenol infusion rather than programmed extrastimulation and burst atrial pacing. A characteristic P-wave morphology and endocardial activation pattern were observed. Positive P-wave in inferior leads was seen in all patients, upright or biphasic ( +/- )component P wave was observed in lead V_1, isoelectric component or an uptight component P wave with low amplitude ( < O0 1 mV) was seen in lead V_2 - V_6. Earliest endocardial activity occurred at the distal coronary sinus (CS) in all patients. The earliest endocardial activation at the successful RFA site occurred (36. 7 ± 7.9 ) ms before the onset of P wave. RFA was successful in all 9 patients immediately post procedure. AT reoccurred in 2 patients within 1 month post RFA and AT disappeared post the 2nd-RFA. AT reoccurred in 1 patient and terminated after the 3rd RFA. At the final follow-up ( 12 ± 5 ) months, all 9 patients were free of arrhythmias without antiarrhythmic drugs. Conclusions The LAA is an uncommon site of origin for focal AT. The characteristic P wave and activation timing are suggestive for focal AT originating from the LAA. LAA focal ablation is safe and effective for patients with focal AT originating from the LAA.